MedTrace Logo

Inappropriate Sinus Tachycardia Registry

NCT05107635 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-10-20

No results posted yet for this study

Summary

The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.

Conditions

  • Inappropriate Sinus Tachycardia
  • Postural Tachycardia Syndrome

Interventions

DEVICE

AtriCure Commercially Available Devices

Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.

Sponsors & Collaborators

  • AtriCure, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2027-01-31
Completion
2027-01-31
FDA Device
Yes

Countries

  • United States
  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05107635 on ClinicalTrials.gov